Alto Neuroscience ANRO Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Alto Neuroscience’s reported figures.
Plus components not separately reported this period.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alto Neuroscience's total debt?
- Alto Neuroscience (ANRO) reported total debt of $20.88M in Q1 2026.
- How has Alto Neuroscience's total debt changed year-over-year?
- Alto Neuroscience's total debt decreased by 17.2% year-over-year, from $25.23M to $20.88M.
- What is the long-term trend for Alto Neuroscience's total debt?
- Over 2 years (2023 to 2025), Alto Neuroscience's total debt has grown at a 47.5% compound annual growth rate (CAGR), from $9.99M to $21.73M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.